Clinical trial · Observational
Clinical Evaluation of GRAPE Model for Gastric Cancer Screening
NCT07067983CI-TRIAL-00092167recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A Prospective Study Evaluating the Performance of the GRAPE Model in Gastric Cancer Screening and Its Detection Rates Across Different Disease Stages
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Results following systematic screening | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- GRAPE systematic screening results
- timeFrame
- first visited at baseline
- description
- Screen-positive individuals after GRAPE systematic screening
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Aged between 18 and 80 years * Individuals undergoing thoracoabdominal CT examination * Voluntarily participated in the study and provided written informed consent Exclusion Criteria: * Patients with confirmed diagnosis of gastric cancer * Individuals with severe intellectual disabilities or communication disorders
References
Publications (0)
Data not yet available
No reference posted for this study.